title: [Necrotizing folliculitis in Behçet's disease].
abstract: We report a 24-year-old man with a known Behcet's disease who was lost to follow-up for a year. The patient was admitted for the association of scrotal ulceration and inguinal folliculitis, suggesting a Behcet's disease flare-up. Necrotizing course of the folliculitis led to the diagnosis of skin infection caused by a community-acquired methicillin-resistant Staphylococcus aureus strain, carrying Panton-Valentine leukocidin genes. Bacteriological analysis should be mandatory in the absence of specific criteria for the diagnosis of Behcet's disease.
authors.affiliation: Service de médecine interne, CHU de la Pitié-Salpêtrière, Université Pierre-et-Marie-Curie Paris-VI, 75651 Paris cedex 13, France. salim.trad@psl.aphp.fr
authors.forename: S
authors.initials: S
authors.lastname: Trad
authors.forename: D
authors.initials: D
authors.lastname: Saadoun
authors.forename: S
authors.initials: S
authors.lastname: Barete
authors.forename: C
authors.initials: C
authors.lastname: Frances
authors.forename: J-C
authors.initials: JC
authors.lastname: Piette
authors.forename: B
authors.initials: B
authors.lastname: Wechsler
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D001427:Bacterial Toxins; D001528:Behcet Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002710:Chlorhexidine / Q000008:administration & dosage / Q000627:therapeutic use; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use; D017714:Community-Acquired Infections; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005098:Exotoxins; D005499:Folliculitis / Q000209:etiology*; D005500:Follow-Up Studies; D006119:Groin; D006801:Humans; D007871:Leg Ulcer / Q000150:complications; D007956:Leukocidins; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification; D009336:Necrosis; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D010630:Phenindione / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D012611:Scrotum; D013207:Staphylococcal Skin Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D013281:Stomatitis, Aphthous / Q000150:complications; D013997:Time Factors; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin; D010630:Phenindione; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D015242:Ofloxacin; C017673:fluindione; D002710:Chlorhexidine; D003078:Colchicine